Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
CPRIT recommends $67 million for nine companies, will negotiate royalties and contract terms
Summary
After due diligence, the oversight committee approved nine product‑development awards totaling about $67 million (negotiated down from $74M requested) and authorized advanced payments upon execution; staff signaled ongoing review of Attachment D revenue‑sharing and royalty terms.
The CPRIT oversight committee approved product development research award recommendations for nine companies following peer review, ranking and due diligence. Doctor Ken Smith (chief product development officer) told the committee the nine companies had requested about $74 million; staff negotiated the package down to approximately $67 million, reserving $7–8 million for supplemental awards in the next cycle.
The slate includes therapeutics, diagnostics and device projects: Iterion Therapeutics (hepatocellular carcinoma…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
